kerry grens

Kerry Grens

Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.

Articles by Kerry Grens
photograph of arabidopsis thaliana with a cantil on a black background
A Newly Found Organ for Arabidopsis
Kerry Grens | Jun 16, 2021 | 2 min read
Horizontal arms dubbed cantils only appear under certain growing conditions—perhaps explaining why they had not been identified before.
blue and white sign for the entrance to the FDA that says U.S. Department of Health and Human Services Food and Drug Administration
Biogen’s Alzheimer’s Drug Gets FDA Approval, Mixed Reviews
Kerry Grens | Jun 7, 2021 | 2 min read
A lackluster performance in clinical trials of the monoclonal antibody aducanumab has left some experts unconvinced of its benefit.
a close up photo of a black dog nose with blond and white whiskers
Dogs: The New COVID-19 Rapid Test
Kerry Grens | May 24, 2021 | 2 min read
Two studies this month point to pooches’ quick detection of SARS-CoV-2 on material that touched the skin of infected participants, although the pups’ accuracy does not match that of RT-PCR.
People with masks on waiting in line outside for covid-19 test swab collection
Rare Fungal Infection Affecting COVID-19 Patients in India
Kerry Grens | May 11, 2021 | 2 min read
Doctors are reporting an uptick in cases of a highly lethal condition called mucormycosis that might be linked to steroid treatments for SARS-CoV-2.
Borrelia burgdorferi Ixodes pacificus chaparral coastal shrubland woodland forest california tick lyme disease
Lyme Disease Pathogen Present in Ticks Near the Coast
Kerry Grens | Apr 26, 2021 | 2 min read
In Northern California, the proportion of ticks infected with the bacterium Borrelia burgdorferi was the same in shrubland along beaches as in woodland habitats.
johnson & johnson johnson&johnson j&j janssen covid-19 vaccine vaccination pandemic adenovirus vector blood clot side effect cerebral venous sinus thrombosis CVST sars-cov-2 coronavirus pandemic astrazeneca
US Health Authorities Ask for Pause in J&J COVID-19 Vaccination
Kerry Grens | Apr 13, 2021 | 2 min read
The FDA and CDC are investigating a handful of reports of blood clots that occurred several days after people received the one-and-done shot.
mis-c multisystem inflammatory syndrome in children covid-19 coronavirus pandemic sars-cov-2 antibody cardiac inflammation icu intensive care kids infection vomiting abdominal pain diarrhea fever
Most Kids with MIS-C Report Few or No COVID-19 Symptoms: Study
Kerry Grens | Apr 7, 2021 | 2 min read
A review of hundreds of cases finds that only a minority of patients noted being sick with a coronavirus infection prior to developing the severe inflammatory condition.
Asher Jones and Kerry Grens | Apr 1, 2021 | 3 min read
Meet some of the people featured in the April 2021 issue of The Scientist.
oxford astrazeneza covid-19 vaccine sars-cov-2 coronavirus pandemic clinical trial phase 2 US chile peru hospitalization
AstraZeneca’s COVID-19 Shot Completely Prevented Severe Disease
Kerry Grens | Mar 22, 2021 | 2 min read
The vaccine was 79 percent effective at blocking symptomatic infections, according to data from a Phase 3 trial in the US, Chile, and Peru. A US safety oversight board says the data might be incomplete.
christmas island gold course australia extinct species Christmas Island forest skink Emoia nativitatis Christmas Island pipistrelle Pipistrellus murrayi
Australian Government Adds a Dozen Animals to Extinct List
Kerry Grens | Mar 3, 2021 | 1 min read
The species include the first reptile to be listed and the Christmas Island pipistrelle, a bat last seen in 2009.